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ABSTRACT : The Carcinoembryonic antigen (CEA), CA19-9 and Tissue 
Polypeptide Antigen (TPA) levels in portal blood in colorectal cancer patients were studied 
in correlation with the peripheral blood levels and histopathologic findings in order to 
know serum levels increased. 1) Portal blood CEA, CA19-9 and TPA increased by operative 
maneuver. 2) Mean values of these markers in portal blood were higher than those in 
peripheral blood. 3) Portal blood CEA was correlated with Dukes' staging, and revealed 
higher positive rates than CEA in peripheral blood in each stage. Portal CA19-9 changed 
within normal value and strikingly rose in Dukes' D stage. Portal TPA tends to be higher 
in all stages and correlated with grades, but the value in Dukes' D were lower than that 
of peripheral blood. 5) Moderately differentiated adenocarcinoma revealed the highest 
level of portal CEA (P<0.05), but portal CA19-9 and TPA did not indicate any correlation 
with cell differentiation. 6) The mean values of portal and peripheral CEA, CA19-9 and 
TPA showed significant elevation in those with infiltration of cancer cells extending 
through the proper muscle layer. This study suggests that the mechanism of these 
markers' transfer from tumor into the portal vein is the most important decisive factor 
of the peripheral levels.
       INTRODUCTION 
 Among various tumor markers of colorectal 
cancer, the carcinoembryonic antigen (CEA) is 
the most valuable tumor marker and its assay 
is now widely used'-4'. On the other hand, CA19-
9 and Tissue Polypeptide Antigen (TPA) are 
also used for colorectal cancer, althoug these 
assays increased in carcinomas of hepatobilliary 
tract, pancreas, stomach and intestine5-7'. How-
ever, about half of the patients with colorectal 
cancer do not indicate elevated levels of these 
markers in peripheral blood. It has been con-
sidered that the level of these markers in pe-
ripheral blood does not fully reflect the cancer 
tissue. Most researches about the mechanism 
of elevated blood levels of the markers have 
been concerned with the assessment of the 
markers in peripheral blood, using the histo-
pathological findings of the tumor'-'), and the 
measurement of markers in extracts of tumor,
but a few has studied portal markers levels" "'. 
In the present study, we measured portal CEA, 
CA19-9 and TPA levels from the blood of the 
drainage vein which was drawn during the 
surgical operations of the patients with col-
orectal cancer, and studied the relationship 
between portal and peripheral levels of the 
markers and histopathological findings.
   MATERIALS AND METHODS 
Patients 
 One-hundred and thirty patients who under-
went resection for primary colorectal cancer at 
the First Deparment of Surgery, Nagasaki 
University Hospital sine 1983 were examined. 
The number of cases which were studied portal 
CEA, CA19-9 and TPA were shown in' Table 1. 
Those who were affected with multiple cancer 
and/or double cancer were excluded. 
Blood-collecting from the portal vein 
 A catheter was inserted into the main trunk 
of the drainage veins from the primary tumor, 
and collected the blood sample from the 
marginal vein close to the tumor. To avoid the 
influence of the surgical maneuver, blood col-
lecting was done immediately after laparotomy. 
On the other hand, to know the alterations of 
the portal blood levels of CEA, CA19-9 and TPA 
caused by the surgical maneuver, portal blood 
sample was also collected at the time of 
resection of the colon and rectum. 
Radioimmunoassay 
 The radioimmunoassays using in this study 
were : Sandwich method using Dinabot-RIA Kit 
in CEA, RIA Kit in CA19-9 and RIA double 
antibody method (Centcorner Co.) in TPA. 
Histopathological Study 
 The section for histological study of the tumor 
was obtained from the central part and bilateral
part of the tumor, and they were fixed in 10% 
formaldehyde and embedded in paraffin and 
stained by hematoxylin and eosin. Dukes' 
staging classification was employed as a meas-
ure of the clinical staging of the colon and 
rectum.
          RESULTS 
Alteration of Portal Levels of CEA, CAI-9-9 and 
TPA during the Operation 
 In order to know the alterations of the portal 
blood levels of the markers which were caused 
by the surgical maneuvers, the portal blood 
samples were collected on laparotomy and on 
resection of the tumor. Portal blood levels on 
resection were higher than those on laparotomy 
in each markers (Fig. 1). The mean CEA levels 
on laparotomy was significantly differed from 
that on resection. The mean values of CA19-
9 and TPA on laparotomy were higher than 
those on resection. However, there were no 
significant differences between the levels im-
mediately after laparotomy and those after 
surgical maneuver, respectively.
Fig. 1. Alterations of the Portal CEA levels by the 
       Surgical Maneuvers
           Table 1. Portal and Peripheral Blood Lever of CEA, CA19-9 and TPA 
                                     Portal values Peripheral values
 Markers No. of Pv>Sv                     p
atients Mean ± SD Positive Mean ± SD Positive (%) 
                                         rate (%) rate (%) 
CEA (2.5ng/ml) 77 13.2 ± 32.3 57.1 8.0 ± 10.2 48.5 75.0 
CA19-9 (37U/ml) 44 38.4 ± 64.9 23.4 38.8±54.7 28.5 83.8 
TPA (100U/L) 47 160 ± 267 65.2 157.8 ± 89.8 55.2 57.9 
 ( ) : Cut off levels Pv : Portal levels Sv : Peripheral levels
Fig. 2. Dukes' stage, Portal CEA and Peripheral 
     CEA
Fig. 4. Dukes' stage, Portal TPA and Peripheral 
     TPA
Portal and Peripheral Values of CEA, CA19-9 
and TPA 
 Table 1 showed the mean values and positive 
rates of CEA, CA19-9 and TPA in portal and 
peripheral blood. In peripheral blood, the pos-
itive rates were 48.5% in CEA, 28.5% in CA19-9 
and 55.2% in TPA. The mean values of CEA 
and TPA were higher than those of cut off levels, 
and the portal values were higher than the 
peripheral ones, but the mean values of portal 
and peripheral CA19-9 were the same of cut off 
levels. The incidence of the cases in which the 
portal levels were higher than the peripheral 
levels were 75% in CEA, 83.8% in CA19-9 and 
57.9% in TPA. 
Dukes' Staging and Portal Levels of CEA, CA19-
9 and TPA 
 The relationship between Dukes' staging and 
portal and peripheral levels of CEA, CA19-9 and 
TPA were shown in Fig. 2, 3 and 4. The mean
Fig. 3. Dukes' stage, Portal CA19-9 and Peripheral 
      CA19-9
value of serial CEA in peripheral blood and in 
the portal blood on Dukes' D stage was sig-
nificantly higher than those on Dukes' A and 
Dukes' B and Dukes' C. In portal CA19-9, Dukes' 
D stage which were accompanying peritoneal 
dissemination and/or liver metastasis revealed 
a remarkable rise with a mean values of 112.7± 
105.4ng/ml. However, there was no close cor-
relation between portal and peripheral levels. 
TPA levels in portal blood tend to be higher 
in all stages with correlation with grades. 
Significant difference between Dukes' A and 
Dukes' B was observed in portal TPA, and the 
levels of Dukes' D were significantly higher than 
those of other stages. But the mean values of 
portal TPA in Dukes' D were lower than that 
of peripheral blood. 
Cancer Invason in Colorectal Wall and Portal and 
Peripheral Levels of CEA, CA19-9 and TPA 
 The mean values of portal and peripheral 
CEA showed significant elevation in those with 
infiltration of cancer cells extending through the 
proper muscle layer (pm). The positive rate of 
portal CEA in those with subserosal or serosal 
invasion was higher than that of peripheral 
CEA. Significant elevation was also noted in 
portal and peripheral CA19-9, same as those of 
CEA, between proper muscle layer and sub-
serosal layer, but the changes of values were 
within normal values. The mean values of 
portal and peripheral TPA were higher in those 
with subserosal layer than in those with proper 
muscle layer, but there was no significant dif-
ference between the values of proper muscle 
layer and that of subserosal layer (Table 2).
Table 2. Cancer Invasion in Colorectal Wall and Portal and Peripheral Levels of CEA, CA19-9 and TPA 
       (Mean ± SD) 
 Cancer CEA (ng/ml) CA19-9 (U/ml) TPA (U/L) 
invasion Portal Peripheral Portal Peripheral Portal Peripheral 
   pm 3.2 ± 2.4* 3.1 ± 2.3* 14.0 ± 9.9* 15.7±12.3` 105.7 ± 69.0 83.9± 62.8 
   ss 10.2 ± 11.3 8.2 ± 10.2 36.3 ± 29.5 34.7±37.1 157.4± 88.0 200.0 ± 251.9 
    s 33.6 ± 31.7 8.7 ± 8.9 28.8 ± 35.6 30.7 ± 22.6 215.1 ± 107.2 125.3 ± 67.5 
   si 22.2±13.1 12.3 ± 13.1 20.7±17.6 43.9±40.6 169.8 ± 62.3 159.1 ± 122.9 
pm : proper muscle layer ss : subserosal layer s : serosal layer 
* Significant difference in cancer invasion extending through pm (p<0.01) by the Student's t test
Table 3. Tumor Differentiation, Portal Values of 
       CEA, CA19-9 and TPA (Mean ± SD) 
Cell dif- CEA CA19-9 TPA 
ferentiation (ng/ml) (U/ml) (U/L) 
Well 6.0± 7.8" 22.7±10.5 140.8± 57.2 
Moderately 18.0±41.4 29.2±27.5 167.0± 98.2 
Poorly 5.1± 3.7 21.5±19.8 384.2±427.3 
Mutinous 6.5± 3.1 43 ±31.7 119.7± 88.0 
* Significant difference between well and moder-
  ately differentiated adenocarcinoma (p<0.05)
Tumor Differentiation and Portal levels of CEA, 
CAI-9-9 and TPA 
 The mean values of portal CEA of moderately 
differentiated adenocarcinoma was significantly 
higher than that of well differentiated andeno-
carcinoma (p<0.05) (Table 3). However, there 
was no significant correlation between cell dif-
ferentiation of adenocarcinoma and peripheral 
blood CEA. Two out of five patients with poorly 
differentiated or mucinous carcinoma were 
positive of portal CEA, but the mean values of 
CEA were lower than that of moderatelety 
differentiated adenocarcinoma. 
 The mean values of portal CA19-9 and TPA 
did not indicate the significant correlation with 
any cell differentiations.
         DISCUSSION 
 In patients with colorectal cancers, several 
factors contributing to elevated peripheral levels 
of tumor markers were pointed out"-"); 1) 
markers' productivity of tumor 2) release of 
markers from tumor into blood stream 3) clear-
ance of circulating tumor markers. In this 
study, we found that portal levels of CEA, CA19-
9 and TPA were higher than peripheral levels
and elevated after surgical maneuvers. This fact 
suggests that most of these markers flows from 
tumor tissues into peripheral blood vessels via 
the portal vein. 
 Portal CEA levels correlated with Dukes' 
grading and reflected the progression of the 
cancer better than peripheral CEA levels. Portal 
CEA levels were especially high in the case of 
tumors with invasion over the intestinal walls. 
What is more, portal CEA levels were found to 
correlate with the differentiation of tumor. 
Pathologically, portal CEA levels were most 
strongly correlated with the progression of 
cancer, that is, cases with cancerous invasion 
over intestinal walls tended to indicate high 
portal CEA levels. In terms of tumor dif-
ferentiation, moderately differentiated adeno-
carcinoma showed significantly higher portal 
CEA levels than well differentiated ones. This 
fact is assumed to reflect the phenomenon 
that moderately differentiated adenocarcinoma 
contains a large amount of CEA and has wide 
distribution of CEA shown by immuno-
histochemical stainingz, 3, 11, 14, On the other 
hand, well differentiated adenocarcinoma re-
vealed low portal CEA levels in comparison with 
other tumor type, though it contained a large 
amount of CEA14'. This can be explained by 
that most of the CEA in the tumor was excreted 
into the lumen of intestine and only a little was 
released into portal vein. Poorly differentiated 
adenocarcinoma and mucinous cancer showed 
low portal CEA levels. This appears to reflect 
the fact that these carcinomas contained low 
CEA3'. Portal CEA levels correlated well with 
invasion of tumor, but not with peripheral CEA 
levels. This difference might be caused mainly 
by the metabolism in the liver, since CEA flows
the portal vein into the systemic circulation 
through the liver"'. 
 Portal CA19-9 levels changed within normal 
value and showed a striking rise in Dukes' D 
stage accompaing peritoneal dissemination and/ 
or liver metastasis. It has been reported that 
positive rate of serum CA19-9 for colorectal 
cancer patients ranged from 21%-36%4' 5, 15) In 
the present syudy, we also found low positive 
rates of portal CA19-9 as well as those of 
peripheral one. Eighty-five per cent of the cases, 
however, had a higher portal CA19-9 levels than 
peripheral CA19-9 levels. It has been reported 
that the colorectal carcinoma contained high 
CA19-9G'. These findings suggests that CA19-
9 transfer from tumor into the portal vein, and 
that the high levels in Dukes' D might be caused 
by production of metastatic lesion. 
 General agreement has been obtained by many 
investigators that serial TPA was not specific 
for colorectal carcinoma, because most of the 
patients with gastrointestinal cancer showed a 
remarkable rise of TPA, and that the positive 
rates of serial TPA for colorectal cancer patients 
were 50%-70%4, 16, 17>. In this study, the portal 
values tend to correlate with Dukes' staging, but 
the mean values of portal TPA in Dukes' D were 
lower than that of peripheral blood. This 
difference might be caused by transfer from 
metastatic tumors and/or by specificity of TPA 
per se such as cytotoxicity or acute phase 
reactant7'17'. It has been also recognized that 
the cancerous tissues of colon and rectum 
contained as high as ten times of TPA values 
as compared to normal colorectal mucosa`'. We 
found that 58% of the cases showed higher levels 
in portal TPA than that in peripheral blood. 
These findings suggest that the mechanism of 
TPA transfer from tumor into portal vein is the 
most important factor to evaluate the TPA 
values in peripheral blood vessels.
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